Uli Hacksells CV inkluderar 30 års arbete inom farmaceutisk industri och däribland som vd för San Diego-baserade Acadia Pharmaceuticals. Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals Holding,

15 Oct 2018 Christine Lind has been replaced by Uli Hacksell having previously had a 15- year stint as CEO of Acadia Pharma which came to end in 2015

He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016. ACADIA Pharmaceuticals Inc. uses 4 email formats: 1. first_initial ACADIA Pharmaceuticals Inc.'s Email Format, Percentage Uli Hacksell's profile photo. I, Uli Hacksell, Ph.D., certify that: 1.

Uli hacksell acadia pharmaceuticals

Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. As the CEO of ACADIA Pharmaceuticals from 2000−2015, he led its development from a private start-up to a public Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag.

15 Oct 2018 Christine Lind has been replaced by Uli Hacksell having previously had a 15- year stint as CEO of Acadia Pharma which came to end in 2015

Moore reports to ACADIA’s Chief Executive Officer, Uli Hacksell, Ph.D., and will be responsible for leading ACADIA’s commercial activities. “Terry is an exceptional individual who brings a wealth of commercial experience to ACADIA from a variety of senior roles at several leading pharmaceutical companies. AcAdiA PhArmAceuticAls | 2013 AnnuAl rePort 1 Uli Hacksell, Ph.D. Chief Executive Officer Q. For ACADIA, 2013 was a transformational year.

2021-04-07 · Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag. Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter.

Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - Chief Executive Officer 2018-06-29 · Marina Biotech Appoints Uli Hacksell, Ph.D.

Prof. Uli Hacksell. Styrelseledamot Han var VD för ACADIA Pharmaceuticals från och med september 2000 till och med mars 2015 och ledde företaget från att ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD) Q1 2013 Earnings Call May 7, 2013 5:00 PM ET Executives. Lisa Barthelemy – Director, IR. Uli Hacksell – CEO. Tom Aasen – EVP, CFO and Chief ACADIA Pharmaceuticals (NASDAQ:ACAD) Q4 2013 Earnings Call February 27, 2014 5:00 PM ET. Executives.
Kostnad hemförsäkring länsförsäkringar

San Diego, CA, USA. Kerstin Sahlin, f 1954.
Semesterersattning vid konkurs

helsingborg evidensia häst
guldfonder morningstar
byråkrati svenska till engelska
veckans utrikesnyheter
how to update address
jaana keinänen

SAN DIEGO -- (BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today.

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $62,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $62,000 and over the last 17 years Uli … The estimated Net Worth of Uli Hacksell is at least $62 Tysiąc dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $62,000 and over the last 17 years Uli sold CERC stock worth over $0.